Law360, New York (February 22, 2006, 12:00 AM ET) -- Takeda Pharmaceutical Company has prevailed in a patent infringement suit filed three years ago against three generic drug makers after a judge upheld the patent covering the key ingredient in the company’s blockbuster diabetes treatment ACTOS.
The ruling dealt a blow to patent challengers Mylan Pharmaceuticals and Alphapharm, both of which had challenged the patent for the active ingredient in the drug.
“Takeda has confidence in its patents," said Mr. Seiji Hakoda, general manager of the Intellectual Property Department of Takeda. "Because innovation is critical to...
Generics Makers Denied In Diabetes Drug Patent Suit
To view the full article, take a free trial now.
